0001104659-10-010939 Sample Contracts

FIRST AMENDMENT TO LOAN AGREEMENT
Loan Agreement • March 1st, 2010 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • Illinois

THIS FIRST AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is made and entered into as of September 30, 2009, between ISIS PHARMACEUTICALS, INC., a Delaware corporation (together with its successors and assigns, “Borrower”), and RBS ASSET FINANCE, INC., a New York corporation (together with its successors and assigns, “Lender”).

AutoNDA by SimpleDocs
AMENDED & RESTATED LICENSE AGREEMENT
License Agreement • March 1st, 2010 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • New York

THIS AMENDED & RESTATED LICENSE AGREEMENT (the “Agreement”) is made and entered into effective as of November 30, 2009 (the “Restatement Date”), by and between ATLANTIC PHARMACEUTICALS LIMITED (formerly ATLANTIC HEALTHCARE (UK) LIMITED registered number 6025726), whose registered office is MoFo Notices Limited, 7th Floor, City Point, One Ropemaker Street, London EC2Y 9AW (“Atlantic”) and ISIS PHARMACEUTICALS, INC., having principal offices at 1896 Rutherford Road, Carlsbad, CA 92008 (“Isis”). Atlantic and Isis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT
License Agreement • March 1st, 2010 • Isis Pharmaceuticals Inc • Pharmaceutical preparations

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED LICENSE AGREEMENT (the “Amendment”) is made and entered into effective as of December 18, 2009 (the “Amendment No. 1 Effective Date”), by and between ONCOGENEX TECHNOLOGIES INC., having offices at #400 — 1001 West Broadway, Vancouver, B.C. V6H 4B1 (“OncoGenex”), and ISIS PHARMACEUTICALS, INC., having principal offices at 1896 Rutherford Road, Carlsbad CA 92008-7208 (“Isis”). OncoGenex and Isis each may be referred to herein individually as a “Party,” or collectively as the “Parties.”

DRUG DEVELOPMENT AND LICENSE OPTION AGREEMENT BETWEEN ELI LILLY AND COMPANY AND ISIS PHARMACEUTICALS, INC. December 2, 2009
Development and License Option Agreement • March 1st, 2010 • Isis Pharmaceuticals Inc • Pharmaceutical preparations • New York

THIS DRUG DEVELOPMENT AND LICENSE OPTION AGREEMENT (the “Agreement”) executed on December 2, 2009 (the “Effective Date”), by and between ELI LILLY AND COMPANY, a corporation organized and existing under the laws of Indiana and its Affiliates (together, “Lilly”), and ISIS PHARMACEUTICALS, INC., a corporation organized and existing under the laws of Delaware and its Affiliates (together, “Isis”).

Time is Money Join Law Insider Premium to draft better contracts faster.